Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Commentary
Cardio Oncology with ACOS
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
Letter to Editor
Media and News
Molecular Insight Story
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Commentary
Cardio Oncology with ACOS
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
Letter to Editor
Media and News
Molecular Insight Story
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication

Year Wise Statistics



Total Downloads
285,164
Fulltext
217,952
PDF
67,212
Articles Fulltext downloads PDF downloads Total downloads
Review Article
Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_12_2023
15,103 1,421 16,524
Original Article
Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_15_2023
14,499 1,378 15,877
Editorial
Challenging conventional wisdom in molecular oncology: New perspectives
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_20_2023
14,468 1,351 15,819
Case Report
Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_16_2023
14,550 1,228 15,778
Review Article
Molecular oncology and the role of artificial intelligence in advancing cancer treatment
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_17_2023
14,306 932 15,238
Editorial
Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_2_2024
9,791 1,192 10,983
Review Article
Understanding immunotherapy and CAR-T-cells: A narrative review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_22_2023
9,952 844 10,796
Review Article
High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_1_2024
9,952 777 10,729
Review Article
Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_3_2024
9,777 764 10,541
Original Article
Spectrum of lymphomas in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2023
9,638 401 10,039
Review Article
Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_29_2022
5,529 980 6,509
Case Report
Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_6_2023
5,349 1,126 6,475
Case Report
L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_11_2023
5,149 740 5,889
Review Article
Potential therapeutic molecular targets for better outcomes for patients with lung cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 2, May-August
DOI: 10.25259/IJMIO_27_2022
5,513 362 5,875
Review Article
Combination of PARPi and anti-PD-L1 therapies in ovarian cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 2, May-August
DOI: 10.25259/IJMIO_28_2022
5,271 520 5,791
Short Communication
Driver mutations in oncogenesis
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_26_2020
4,564 633 5,197
Review Article
Advances in immunotherapy for metastatic esophageal cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 3, September-December
DOI: 10.25259/IJMIO_14_2022
804 1,598 2,402
Original Article
Prevalence of germline mutations in women with breast and/or ovarian cancer in a tertiary care center in Pune, India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 2, May-August
DOI: 10.25259/IJMIO_5_2023
1,594 442 2,036
Review Article
Is continuous infusion of high-dose ifosfamide, a safe option? Drug review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_21_2019
1,335 576 1,911
Review Article
Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_17_2019
768 1,010 1,778
Review Article
Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_12_2021
806 969 1,775
Brief Commentary
ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_10_2021
621 1,039 1,660
Review Article
Immune dynamics of SARS-CoV-2 virus evolution
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_26_2021
588 996 1,584
Short Communication
Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI: 10.25259/IJMIO_30_2020
1,141 424 1,565
Case Report
Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_5_2022
930 612 1,542
Review Article
Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_12_2022
760 753 1,513
Review Article
Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_8_2022
1,062 446 1,508
Brief Commentary
Breast cancer prognostic tools: A promising Indian option
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_15_2020
835 634 1,469
Review Article
Molecular genetics changes in gallbladder carcinoma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_19_2019
937 488 1,425
Review Article
The Cancer Genomic Atlas – “TO CONQUER CANCER”
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_28_2020
822 560 1,382
New Drug Update
Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_13_2021
512 868 1,380
Editorial
Molecular insights into tumor microenvironment and targeted therapies
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_28_2021
501 878 1,379
Review Article
Immuno-oncology of differentiated thyroid cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_36_2020
863 494 1,357
Case Report
Complete metabolic response with letrozole and palbociclib in advanced breast cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI: 10.25259/IJMIO_2_2019
655 670 1,325
Review Article
Alpha-fetoprotein: A molecular bootstrap for hepatocellular carcinoma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 3, September-December
DOI: 10.25259/IJMIO_5_2020
1,028 287 1,315
Review Article
Molecular targets in urinary bladder cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 3, September-December
DOI: 10.25259/IJMIO_4_2022
870 397 1,267
Review Article
HER2 ‘neu’ promise for mCRC
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 1, January-April
DOI: 10.25259/IJMIO_30_2022
470 769 1,239
Original Article
Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_15_2021
581 657 1,238
News
Editorial board tribute to Dr. Amit Verma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
787 436 1,223
Review Article
A compendium of population wide DNA methylation profile for oral cancer in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_2_2021
610 608 1,218
Original Article
Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_2_2022
607 604 1,211
Short Communication
Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI: 10.25259/IJMIO_30_2020
826 370 1,196
Editorial
Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_23_2019
378 802 1,180
Review Article
The evolving role of precision medicine in the management of advanced sarcomas – A mini review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_6_2021
717 416 1,133
Review Article
Clinical application of molecular genetics in acute myeloid leukemia
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 3, September-December
DOI: 10.25259/IJMIO_22_2022
820 313 1,133
Review Article
Clinical trials landscape in Sri Lanka
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_29_2020
823 306 1,129
Original Article
Assessment of mismatch repair protein expression by immunohistochemistry in endometrial carcinomas with clinicopathological correlation: A study from Indian Tertiary Cancer Care Centre
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 3, September-December
DOI: 10.25259/IJMIO_17_2020
940 189 1,129
Editorial
Bench to clinic – Molecular oncology fast tracking cures
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 1, January-April
DOI: 10.25259/IJMIO_3_2023
490 637 1,127
Cardio Oncology with ACOS
Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_1_2022
571 511 1,082
Case Report
Metastatic endometrial carcinoma responsive to pembrolizumab
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2020
555 521 1,076